Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pathogenesis of Chronic Diarrhoea After Right-Sided Colon Cancer Surgery
NCT04003181Completed
- Sponsor
- Aarhus University
- Start
- Sep 2017
- Primary completion
- May 2021
- Modality
- Polymer-based Nanoparticles, Device-based Delivery, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ciprofloxacin, rifaximin, cholestyramine and colesevelam in Chronic diarrhea (3 arms), sponsored by Aarhus University. Primary endpoints: Change in SeHCAT retention after 7 days and Serum concentration of FGF19 at 1 month. Started Sep 2017; status: completed.
02
Drugs
ciprofloxacinrifaximincholestyraminecolesevelam
03
Conditions
Chronic diarrhea
Beyond the preview
Go deeper on NCT04003181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04003181.